Potential for erroneous results indicating resistance when using the Bactec MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide
about
Systematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in Mycobacterium tuberculosis clinical isolatesA Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-AnalysisRapid colorimetric testing for pyrazinamide susceptibility of M. tuberculosis by a PCR-based in-vitro synthesized pyrazinamidase methodAssociation between Mycobacterium tuberculosis complex phylogenetic lineage and acquired drug resistanceDrug Susceptibility Patterns in MDR-TB Patients: Challenges for Future Regimen Design. A Cross-Sectional StudyReevaluation of the critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide using wild-type MIC distributions and pncA gene sequencing.Comparison and development of pyrazinamide susceptibility testing methods for tuberculosis in Thailand.Outbreak of pyrazinamide-monoresistant tuberculosis identified using genotype cluster and social media analysis.Pyrazinamide susceptibility testing of Mycobacterium tuberculosis by high resolution melt analysis.Rapid sequencing of the Mycobacterium tuberculosis pncA gene for detection of pyrazinamide susceptibility.Phenotypic and genotypic characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Zhejiang, ChinaValidation of pncA gene sequencing in combination with the mycobacterial growth indicator tube method to test susceptibility of Mycobacterium tuberculosis to pyrazinamide.Epidemiology of pyrazinamide-resistant tuberculosis in the United States, 1999-2009Genotypic characterization of drug resistant Mycobacterium tuberculosis in Quebec, 2002-2012.Improved Detection by Next-Generation Sequencing of Pyrazinamide Resistance in Mycobacterium tuberculosis Isolates.Importance of the genetic diversity within the Mycobacterium tuberculosis complex for the development of novel antibiotics and diagnostic tests of drug resistanceEvaluation of methods for testing the susceptibility of clinical Mycobacterium tuberculosis isolates to pyrazinamide.Direct Susceptibility Testing of Mycobacterium tuberculosis for Pyrazinamide by Use of the Bactec MGIT 960 System.Drug resistance patterns in 111 cases of drug-resistant tuberculosis spine.Pyrazinamide Is Active against Mycobacterium tuberculosis Cultures at Neutral pH and Low Temperature.Prevalence of pyrazinamide resistance across the spectrum of drug resistant phenotypes of Mycobacterium tuberculosisRole of pncA and rpsA gene sequencing in detection of pyrazinamide resistance in Mycobacterium tuberculosis isolates from southern China.Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses.Pyrazinamide: the importance of uncovering the mechanisms of action in mycobacteria.'Z(S)-MDR-TB' versus 'Z(R)-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibilityEvaluation of a novel line probe assay to detect resistance to pyrazinamide, a key drug used for tuberculosis treatment.Prevalence and transmission of pyrazinamide resistant Mycobacterium tuberculosis in ChinaImproved Bactec MGIT 960 Pyrazinamide Test Decreases Detection of False Mycobacterium tuberculosis Pyrazinamide Resistance.Gene sequencing for routine verification of pyrazinamide resistance in Mycobacterium tuberculosis: a role for pncA but not rpsA.A comprehensive characterization of PncA polymorphisms that confer resistance to pyrazinamide.Prevention of false resistance results obtained in testing the susceptibility of Mycobacterium tuberculosis to pyrazinamide with the Bactec MGIT 960 system using a reduced inoculum.Evaluation of a biphasic media assay for pyrazinamide drug susceptibility testing of Mycobacterium tuberculosis.Molecular analysis of pyrazinamide resistance in Mycobacterium tuberculosis in Vietnam highlights the high rate of pyrazinamide resistance-associated mutations in clinical isolates.Using Reduced Inoculum Densities of Mycobacterium tuberculosis in MGIT Pyrazinamide Susceptibility Testing to Prevent False-Resistant Results and Improve Accuracy: A Multicenter Evaluation.Practice Guidelines for Clinical Microbiology Laboratories: Mycobacteria.A Rapid Growth-Independent Antibiotic Resistance Detection Test by SYBR Green/Propidium Iodide Viability Assay.
P2860
Q27004697-CBB22E19-84E4-40BA-AB83-1052236A1120Q27011264-8BA8A74C-74D4-4010-82E8-8EC22FD7B576Q28477917-38C60E49-254D-4A43-A2F9-09D58BF1F0BAQ28537951-304BBFD5-99EF-4E13-A193-7006317E8F23Q28550883-D6E0261B-B2FD-4575-AEAE-AFFB0D7A6478Q30224832-040925EF-746E-45CF-A247-851B0ED32CBDQ30278824-93457AA5-DAB3-404C-BADD-E93255CC1317Q30405961-06AE2246-0BF8-4C4C-A764-9231E844779AQ30408918-910AB22F-4F6E-4590-BC35-DEAC44DFD047Q35036087-7265E97C-D25C-46C4-A3BA-BB529666B6BEQ35076847-DCDB53C7-3CC3-4ED7-A8FE-8029A2DBCB3FQ35689060-51A4E742-6493-46C0-B7EF-9DE05EF8BA27Q36082638-DFC27E17-412A-4332-B5E5-915F6223F8D6Q36086220-885B8101-7A80-412D-B924-BFF544856200Q36297624-0789509F-A09F-48F7-BB8F-33F1B5DC2132Q36396241-2A983985-B72E-42B9-AC87-57714BBDAF36Q36826734-64404AFB-0CF1-4611-8509-DDDC135C5E4EQ36834801-7F1C3087-8AE4-4036-A301-9FF21DFA45FDQ36951876-91F841D9-31AC-43B2-BE7F-10413AA2B4D8Q37120038-A2017DC8-9B88-4AC0-B801-F7A7DFB58A4AQ37133281-121A16DE-A8A2-4FEC-9495-AEA267E535E9Q37546627-EA909142-82A9-436A-8146-7703E2150A5AQ37902409-991564FC-9982-488E-9505-06D8056D88A8Q38368943-E63CD9D6-95BB-4D10-92C5-DBE20C6C9373Q38514218-1C390686-A1C2-48DE-928B-79A8BDD8143DQ38739933-FA07BC09-DD56-4FED-A684-2C91C2AB2BDEQ39785436-7389278F-6EAA-451E-B4A4-D83B95F8BD3AQ40048055-94403C76-F588-4C22-B5F5-A884B453E0C2Q41580259-14FC06A8-450C-4D37-A83A-C9AEB1559A0AQ41701192-C51EDF69-B0DB-4CE9-8F16-45D5263403C2Q42127991-1BF9FB12-EDD5-4B14-B4AD-14ECE342D92FQ42209072-CE20C161-A09D-4164-9CB2-89FA3CC5F78BQ42618592-086C8C74-79FC-4227-9A3F-4878FFD52B90Q46765284-F10E1C12-E697-4039-AB5A-45285A15F4F6Q47554066-5F083163-356D-4BC6-952B-116F200BCE02Q55239147-45FB5281-CF06-4B45-A5DD-1E777748134E
P2860
Potential for erroneous results indicating resistance when using the Bactec MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Potential for erroneous result ...... m tuberculosis to pyrazinamide
@ast
Potential for erroneous result ...... m tuberculosis to pyrazinamide
@en
type
label
Potential for erroneous result ...... m tuberculosis to pyrazinamide
@ast
Potential for erroneous result ...... m tuberculosis to pyrazinamide
@en
prefLabel
Potential for erroneous result ...... m tuberculosis to pyrazinamide
@ast
Potential for erroneous result ...... m tuberculosis to pyrazinamide
@en
P2093
P2860
P356
P1476
Potential for erroneous result ...... m tuberculosis to pyrazinamide
@en
P2093
Frances Jamieson
Joyce Wolfe
Lina Bertucci
Meenu Sharma
Pamela Chedore
P2860
P304
P356
10.1128/JCM.01775-09
P407
P577
2009-11-18T00:00:00Z